Seronegative SpA and its treatment monitoring ESSR 2022 Skills Posted on September 18, 2023 ← Monitoring modern treatment response in arthritis – findings in MRI and ultrasound How to monitor musculoskeletal manifestations of neurofibromatosis type-1 and tuberous sclerosis →